Skip to main content
SpringerLink
Log in

Possible relationship between golimumab and meningitis

  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Arias AE. Golimumab and Meningitis. WHO Pharmaceuticals Newsletter : 27-29, No. 6, Dec 2013. Available from: URL: http://www.who.int/medicines/publications/NewsletterNo6_2013EC.pdf.

  2. Janssen Biologics. Response from Janssen Biologics B.V. (re: Golimumab and Meningitis). WHO Pharmaceuticals Newsletter : 29, No. 6, Dec 2013. Available from: URL: http://www.who.int/medicines/publications/NewsletterNo6_2013EC.pdf.

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Possible relationship between golimumab and meningitis. Reactions Weekly 1488, 2 (2014). https://doi.org/10.1007/s40278-014-8747-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-8747-x

Search

Navigation